Jin Medical International (ZJYL) Raw Materials (2022 - 2026)

Jin Medical International has disclosed Raw Materials across 5 years of filings, most recently posting $2.4 million for Q1 2026.

• In Q1 2026, Raw Materials rose 14.66% year-over-year to $2.4 million; the TTM figure through Mar 2026 stood at $2.4 million (up 14.66% YoY), while the FY2025 annual figure was $2.1 million, up 1.76% from the prior year.
• Raw Materials came in at $2.4 million for Q1 2026 at Jin Medical International, up from $2.1 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $3.3 million in Q3 2022 to a low of $2.1 million in Q3 2024.
• Average Raw Materials over 5 years is $2.5 million, with a median of $2.4 million recorded in 2024.
• Year-over-year, Raw Materials retreated 21.31% in 2024 and increased 14.66% in 2026.
• Over 5 years, Raw Materials stood at $3.3 million in 2022, then decreased by 20.04% to $2.6 million in 2023, then dropped by 21.31% to $2.1 million in 2024, then grew by 1.76% to $2.1 million in 2025, then rose by 14.73% to $2.4 million in 2026.
• Per Business Quant data, the three most recent Raw Materials figures were $2.4 million in Q1 2026, $2.1 million in Q3 2025, and $2.1 million in Q1 2025.